AstraZeneca India plunges; delisting decision delayed

AstraZeneca Pharma India shares plunge after its board late on Wednesday deferred a proposal to delist the company from Indian exchanges.

The board deferred the proposal saying it would seek additional information from its promoter AstraZeneca Pharmaceuticals AB Sweden, which had sought the delisting.

AstraZeneca shares surged 47 percent in the four trading sessions till Tuesday on expectation that the delisting price would be at a substantial premium to the existing market price of the company.

AstraZeneca shares down 7.6 percent at 1,086 rupees as of 11.13 p.m.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • The current value of the rupee does not merit market intervention

    The rupee, losing 40 paise per month against the dollar since May, is expected to remain under pressure till the calendar runs out on December 31, bef

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Sustainable model for rural sanitation

Prime minister Narendra Modi has promised to build a toilet ...

Zehra Naqvi

How smells evoke strong memories

Remember that time when a passing fragrance transported you to ...

Dharmendra Khandal

Indian zoos need a fresh approach

Recently, when a man jumped in a tiger trench of ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture